Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin for Alcohol Dependence
NCT00585780Phase 2Completed
- Sponsor
- Yale University
- Start
- Sep 2009
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prazosin in alcohol dependence (4 arms), sponsored by Yale University. Primary endpoints: Percentage of Heavy Drinking Days and Percentage of Drinking Days. Started Sep 2009; status: completed.
02
Drugs
prazosin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00585780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585780.